Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Maintenance Treatment With Capecitabine in Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- N/A
STAR Cape+BKM120 MBC With Brain Met
- Status
- COMPLETED
- Phase
- PHASE2
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC
- Status
- COMPLETED
- Phase
- PHASE3
Study of Andrographolides With or Without Capecitabine to Treat Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.
- Status
- COMPLETED
- Phase
- PHASE2